ZVS-207e

N/A

Report date: 2024/09/29 14:52:34

Base Information

Drug NameZVS-207e
Drug Alias NameZVS-207eZVS207e
ClassificationCell and gene therapy > Gene therapy > Gene editing
Mechanisms of Actionpre-mRNA splicing regulator USH1G gene transference
Targetspre-mRNA splicing regulator USH1G
Therapy Area/IndicationsUsher Syndromes
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBeijing Chinagene Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Chinagene Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsUsher Syndromes
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A